| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |